Skip to main content

Advertisement

SpringerLink
Log in

Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool

  • Original Article
  • Published:
Digestive Diseases and Sciences Aims and scope Submit manuscript

Abstract

Few instruments have been developed and validated for the evaluation of multi-dimensional GI symptoms. The Gastrointestinal Symptoms Severity Index (GISSI), a multi-dimensional, self-report instrument, was designed as a brief measure of the frequency, severity, and bothersomeness of individual GI and pelvic floor/urogynecologic symptoms.

Aim

To report the psychometric properties of the GISSI subscales, including factorial structure, validity, and internal consistency.

Methods

The GISSI included 32 items that assessed upper and lower GI symptoms and seven items related to pelvic floor/urogynecologic symptoms. A total of 934 patients presenting for upper and lower GI complaints completed the questionnaire between January 2013 and December 2013. The sample was randomly split into derivation (n = 466) and validation datasets (n = 468). A non-patient sample of 200 was collected separately.

Results

Exploratory factor analysis supported a six-factor model for the derivation sample that accounted for 69.3 % of the total variance. The six GI symptom clusters were labeled as constipation/difficult defecation (five items), abdominal pain/discomfort (four items), dyspepsia (four items), diarrhea/anal incontinence (four items), GERD/chest symptoms (four items), and nausea/vomiting (two items). Inclusion of additional items related to female pelvic floor/urogynecologic symptoms resulted in a separate factor. Confirmatory factor analysis of the validation dataset supported the a priori hypothesized six-factor measurement model (Χ 2(428) = 1462.98; P < 0.001; GFI = .88; RMSEA = .051).

Conclusion

The GISSI demonstrated good to excellent psychometric properties and provided multi-dimensional scaling of prominent GI symptom clusters. Further validation may provide an efficient, valid, and reliable measure of patient-reported clinical outcomes.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Fig. 1

Similar content being viewed by others

Abbreviations

CFA:

Confirmatory factor analysis

EFA:

Exploratory factor analysis

FD:

Functional dyspepsia

FGIDs:

Functional gastrointestinal disorders

GERD:

Gastroesophageal reflux disease

GISSI:

Gastrointestinal Symptoms Severity Index

IBS:

Irritable bowel syndrome

References

  1. Badia X, Mearin F, Balboa A, et al. Burden of illness in irritable bowel syndrome comparing Rome I and Rome II criteria. PharmacoEconomics. 2002;20:749–758.

    Article  PubMed  Google Scholar 

  2. Sandler RS, Everhart JE, Donowitz M, et al. The burden of selected digestive diseases in the United States. Gastroenterology. 2002;122:1500–1511.

    Article  PubMed  Google Scholar 

  3. Camilleri M, Heading RC, Thompson WG. Clinical perspectives, mechanisms, diagnosis and management of irritable bowel syndrome. Aliment Pharmacol Ther. 2002;16:1407–1430.

    Article  CAS  PubMed  Google Scholar 

  4. Shaheen NJ, Hansen RA, Morgan DR, et al. The burden of gastrointestinal and liver diseases, 2006. Am J Gastroenterol. 2006;101:2128–2138.

    Article  PubMed  Google Scholar 

  5. Taub E, Cuevas JL, Cook EW III, et al. Irritable bowel syndrome defined by factor analysis. Gender and race comparisons. Dig Dis Sci. 1995;40:2647–2655.

    Article  CAS  PubMed  Google Scholar 

  6. Whitehead WE, Crowell MD, Bosmajian L, et al. Existence of irritable bowel syndrome supported by factor analysis of symptoms in two community samples. Gastroenterology. 1990;98:336–340.

    CAS  PubMed  Google Scholar 

  7. Ragnarsson G, Bodemar G. Division of the irritable bowel syndrome into subgroups on the basis of daily recorded symptoms in two outpatients samples. Scand J Gastroenterol. 1999;34:993–1000.

    Article  CAS  PubMed  Google Scholar 

  8. Talley NJ, Zinsmeister AR, Melton LJ III. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol. 1995;142:76–83.

    CAS  PubMed  Google Scholar 

  9. Thompson WG, Longstreth GF, Drossman DA, et al. Functional bowel disorders and functional abdominal pain. Gut. 1999;45:II43–II47.

    PubMed Central  PubMed  Google Scholar 

  10. Evans PR, Bak YT, Shuter B, et al. Gastroparesis and small bowel dysmotility in irritable bowel syndrome. Dig Dis Sci. 1997;42:2087–2093.

    Article  CAS  PubMed  Google Scholar 

  11. Whitehead WE, Gibbs NA, Li Z, et al. Is functional dyspepsia just a subset of the irritable bowel syndrome? Bailliere’s Clin Gastroenterol. 1998;12:443–461.

    Article  CAS  Google Scholar 

  12. Talley NJ, Dennis EH, Schettler-Duncan VA, et al. Overlapping upper and lower gastrointestinal symptoms in irritable bowel syndrome patients with constipation or diarrhea. Am J Gastroenterol. 2003;98:2454–2459.

    Article  PubMed  Google Scholar 

  13. Choung RS, Herrick LM, Locke GR III, et al. Irritable bowel syndrome and chronic pelvic pain: a population-based study. J Clin Gastroenterol. 2010;44:696–701.

    PubMed Central  PubMed  Google Scholar 

  14. Talley NJ, Haque M, Wyeth JW, et al. Development of a new dyspepsia impact scale: the Nepean Dyspepsia Index. Aliment Pharmacol Ther. 1999;13:225–235.

    Article  CAS  PubMed  Google Scholar 

  15. Drossman DA, Patrick DL, Whitehead WE, et al. Further validation of the IBS-QOL: a disease-specific quality-of-life questionnaire. Am J Gastroenterol. 2000;95:999–1007.

    Article  CAS  PubMed  Google Scholar 

  16. Rentz AM, Kahrilas P, Stanghellini V, et al. Development and psychometric evaluation of the patient assessment of upper gastrointestinal symptom severity index (PAGI-SYM) in patients with upper gastrointestinal disorders. Qual Life Res. 2004;13:1737–1749.

    Article  CAS  PubMed  Google Scholar 

  17. Revicki DA, Camilleri M, Kuo B, et al. Development and content validity of a gastroparesis cardinal symptom index daily diary. Aliment Pharmacol Ther. 2009;30:670–680.

    Article  CAS  PubMed  Google Scholar 

  18. McElhiney J, Lohse MR, Arora AS, et al. The Mayo Dysphagia Questionnaire-30: documentation of reliability and validity of a tool for interventional trials in adults with esophageal disease. Dysphagia. 2010;25:221–230.

    Article  PubMed  Google Scholar 

  19. Svedlund J, Sjodin I, Dotevall G. GSRS—a clinical rating scale for gastrointestinal symptoms in patients with irritable bowel syndrome and peptic ulcer disease. Dig Dis Sci. 1988;33:129–134.

    Article  CAS  PubMed  Google Scholar 

  20. Francis CY, Morris J, Whorwell PJ. The irritable bowel severity scoring system: a simple method of monitoring irritable bowel syndrome and its progress. Aliment Pharmacol Ther. 1997;11:395–402.

    Article  CAS  PubMed  Google Scholar 

  21. Talley NJ, Phillips SF, Melton J III, et al. A patient questionnaire to identify bowel disease. Ann Intern Med. 1989;111:671–674.

    Article  CAS  PubMed  Google Scholar 

  22. Talley NJ, Phillips SF, Wiltgen CM, et al. Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc. 1990;65:1456–1479.

    Article  CAS  PubMed  Google Scholar 

  23. Cronbach L. Coefficient alpha and the internal structure of tests. Psychometrika. 1951;16:297–334.

    Article  Google Scholar 

  24. Suares NC, Ford AC. Prevalence of, and risk factors for, chronic idiopathic constipation in the community: systematic review and meta-analysis. Am J Gastroenterol. 2011;106:1582–1591; quiz 1581, 1592.

  25. Lovell RM, Ford AC. Global prevalence of and risk factors for irritable bowel syndrome: a meta-analysis. Clin Gastroenterol Hepatol. 2012;10:712 e4–721 e4.

    Article  Google Scholar 

  26. El-Serag HB, Talley NJ. Systemic review: the prevalence and clinical course of functional dyspepsia. Aliment Pharmacol Ther. 2004;19:643–654.

    Article  CAS  PubMed  Google Scholar 

  27. Levy RL, Von Korff M, Whitehead WE, et al. Costs of care for irritable bowel syndrome patients in a health maintenance organization. Am J Gastroenterol. 2001;96:3122–3129.

    Article  CAS  PubMed  Google Scholar 

  28. Talley NJ. Functional gastrointestinal disorders as a public health problem. Neurogastroenterol Motil. 2008;20:121–129.

    Article  PubMed  Google Scholar 

  29. American Gastroenterological Association. American Gastroenterological Association medical position statement: irritable bowel syndrome. Gastroenterology. 2002;123:2105–2107.

    Article  Google Scholar 

  30. Lacy BE, Weiser KT, Kennedy AT, et al. Functional dyspepsia: the economic impact to patients. Aliment Pharmacol Ther. 2013;38:170–177.

    Article  CAS  PubMed  Google Scholar 

  31. Drossman DA, Dumitrascu DL. Rome III: new standard for functional gastrointestinal disorders. J Gastrointest Liver Dis. 2006;15:237–241.

    Google Scholar 

  32. Drossman D, Corazziari E, Talley N, et al., eds. ROME II: The Functional Gastrointestinal Disorders. 2nd ed. McLean, VA: Degnon Associates; 2000.

    Google Scholar 

  33. Spiegel BM, Hays RD, Bolus R, et al. Development of the NIH patient-reported outcomes measurement information system (PROMIS) gastrointestinal symptom scales. Am J Gastroenterol. 2014;109:1804–1814.

    Article  PubMed Central  PubMed  Google Scholar 

Download references

Conflict of interest

None.

Author information

Authors and Affiliations

  1. Division of Gastroenterology and Hepatology, Mayo Clinic Arizona, 13400 East Shea Blvd, Scottsdale, AZ, 85259, USA

    Michael D. Crowell, Sarah B. Umar & John K. DiBaise

  2. Gastroenterology and Hepatology, Dartmouth-Hitchcock Medical Center, Lebanon, NH, USA

    Brian E. Lacy

  3. Gastroenterology, Henrico Doctor’s Hospital, Richmond, VA, USA

    Michael P. Jones

  4. University of Newcastle, Newcastle, Australia

    Nicholas J. Talley

Authors
  1. Michael D. Crowell
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Sarah B. Umar
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Brian E. Lacy
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Michael P. Jones
    View author publications

    You can also search for this author in PubMed Google Scholar

  5. John K. DiBaise
    View author publications

    You can also search for this author in PubMed Google Scholar

  6. Nicholas J. Talley
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to Michael D. Crowell.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Crowell, M.D., Umar, S.B., Lacy, B.E. et al. Multi-Dimensional Gastrointestinal Symptom Severity Index: Validation of a Brief GI Symptom Assessment Tool. Dig Dis Sci 60, 2270–2279 (2015). https://doi.org/10.1007/s10620-015-3647-3

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s10620-015-3647-3

Keywords

Search

Navigation